Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques. 2022

Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE) Hokkaido University, Sapporo, Japan.

Although antibody-inducing split virus vaccines (SV) are currently the most effective way to combat seasonal influenza, their efficacy can be modest, especially in immunologically-naïve individuals. We investigated immune responses towards inactivated whole influenza virus particle vaccine (WPV) formulations, predicated to be more immunogenic, in a non-human primate model, as an important step towards clinical testing in humans. Comprehensive analyses were used to capture 46 immune parameters to profile how WPV-induced responses differed to those elicited by antigenically-similar SV formulations. Naïve cynomolgus macaques vaccinated with either monovalent or quadrivalent WPV consistently induced stronger antibody responses and hemagglutination inhibition (HI) antibody titres against vaccine-matched viruses compared to SV formulations, while acute reactogenic effects were similar. Responses in WPV-primed animals were further increased by boosting with the same formulation, conversely to modest responses after priming and boosting with SV. 28-parameter multiplex bead array defined key antibody features and showed that while both WPV and SV induced elevated IgG responses against A/H1N1 nucleoprotein, only WPV increased IgG responses against A/H1N1 hemagglutinin (HA) and HA-Stem, and higher IgA responses to A/H1N1-HA after each vaccine dose. Antibodies to A/H1N1-HA and HA-Stem that could engage FcγR2a and FcγR3a were also present at higher levels after one dose of WPV compared to SV and remained elevated after the second dose. Furthermore, WPV-enhanced antibody responses were associated with higher frequencies of HA-specific B-cells and IFN-γ-producing CD4+ T-cell responses. Our data additionally demonstrate stronger boosting of HI titres by WPV following prior infection and support WPV administered as a priming dose irrespective of the follow up vaccine for the second dose. Our findings thus show that compared to SV vaccination, WPV-induced humoral responses are significantly increased in scope and magnitude, advocating WPV vaccination regimens for priming immunologically-naïve individuals and also in the event of a pandemic outbreak.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D009698 Nucleoproteins Proteins conjugated with nucleic acids. Nucleoprotein
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006388 Hemagglutinins Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Isohemagglutinins,Exohemagglutinins,Hemagglutinin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
June 2022, Vaccine,
Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
January 2023, Vaccine,
Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
January 1990, Biologicals : journal of the International Association of Biological Standardization,
Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
November 2006, Vaccine,
Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
December 1977, The Journal of infectious diseases,
Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
January 1977, Journal of biological standardization,
Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
February 1951, California medicine,
Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
June 1974, Infection and immunity,
Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
September 2008, Vaccine,
Brendon Y Chua, and Toshiki Sekiya, and Marios Koutsakos, and Naoki Nomura, and Louise C Rowntree, and Thi H O Nguyen, and Hayley A McQuilten, and Marumi Ohno, and Yuki Ohara, and Tomohiro Nishimura, and Masafumi Endo, and Yasushi Itoh, and Jennifer R Habel, and Kevin J Selva, and Adam K Wheatley, and Bruce D Wines, and P Mark Hogarth, and Stephen J Kent, and Amy W Chung, and David C Jackson, and Lorena E Brown, and Masashi Shingai, and Katherine Kedzierska, and Hiroshi Kida
March 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!